Hshs Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 18-07-2024
- Paid Up Capital ₹ 0.50 M
as on 18-07-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.00 M
as on 18-07-2024
- Revenue -12.87%
(FY 2023)
- Profit -326.29%
(FY 2023)
- Ebitda -270.63%
(FY 2023)
- Net Worth -81.33%
(FY 2023)
- Total Assets 46.62%
(FY 2023)
About Hshs Nutraceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.00 Cr.
Zeenat Khan, Hetal Desai, and Hiren Desai serve as directors at the Company.
- CIN/LLPIN
U51909GJ2019PLC111035
- Company No.
111035
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hshs Nutraceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hiren Desai  | Managing Director | 26-Nov-2019 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Zeenat Khan | Director | 26-Nov-2019 | Current |
| Hetal Desai | Director | 26-Nov-2019 | Current |
Financial Performance and Corporate Structure Insights of Hshs Nutraceuticals.
Hshs Nutraceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.87% decrease. The company also saw a substantial fall in profitability, with a 326.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 81.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hshs Nutraceuticals?
In 2023, Hshs Nutraceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Feb 2023 | ₹1.00 Cr | Open |
How Many Employees Work at Hshs Nutraceuticals?
Hshs Nutraceuticals has a workforce of 7 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hshs Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hshs Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
